Genomic Health Company Updates | Glassdoor.co.in

Company Updates

  • Our Talent Acquisition team enjoying our summer BBQ for GHI employees! So much fun. Just another example of how we build community here at Genomic Health.

    http://glassdoor.com/slink.htm?key=vMteL
      #team #talentacquisition #employees #somuchfun

    Join Our Team - Life, Changing Careers | Genomic Health, Inc.

    Be a part of the world's leading provider of genomic cancer diagnostic tests. Make a difference in the lives of patients with cancer.

  • Congrats to Dr. Steven Shak, our co-founder, recognized as a pioneer and visionary for his work in personalized medicine to revolutionize cancer care!

    http://glassdoor.com/slink.htm?key=vMFFd #personalizedmedicine #cancercare #visionary #founder #pioneer

    Personalized Medicine Coalition - Advocates for precision medicine : PMC Press Releases : Press Releases : PMC Selects Dr. Steven Shak as Winner of 15th Annual Leadership in Personalized Medicine Award

    PMC Selects Dr. Steven Shak as Winner of 15th Annual Leadership in Personalized Medicine Award In recognition of visionary scientific research underpinning two flagship personalized medicine products - a therapy and a diagnostic - that have revolutionized cancer care, the Personalized Medicine Coalition (PMC) is pleased to announce that it has selected Dr. Steven Shak, Co-Founder, Chief Scientific Officer, Genomic Health, as the recipient of the 15th Annual Leadership in Personalized Medicine Award.

  • http://glassdoor.com/slink.htm?key=vMBDu
    The No Matter My Age campaign focuses on raising awareness about the need for all breast cancer patients, regardless of age, to get as much information as they can before making a treatment decision.

  • http://glassdoor.com/slink.htm?key=vM96h

    Secondary Analysis of Landmark TAILORx Results, Published Today in The New England Journal of Medicine, Affirms Unique Ability of Oncotype DX Breast Recurrence Score® to Predict Chemotherapy Benefit, Guiding Adjuvant Therapy with Even Greater Precision

  • We’re pleased to share the first story that aired on NBC in Columbus, Ohio featuring Deepa Halaharvi. The segment includes an interview with Deepa about her experience with Oncotype DX as both a physician and patient. It also highlights the TAILORx results and that NCCN considers the Oncotype DX test a “preferred method.” You can view the story on NBC’s website. Enjoy!

    http://glassdoor.com/slink.htm?key=vM9Hi

    Movement aims to help breast cancer patients choose best treatment for them

    Women diagnosed with the most common form of breast cancer may be getting unnecessary chemotherapy, according to a breast cancer surgeon.

  • We are pleased to announce the publication of results of a large prospective trial validating the detection of AR-V7 biomarker using Epic Sciences AR-V7 test, commercialized in the US as Oncotype DX® AR-V7 Nucleus Detect™by Genomic Health. Press release: http://glassdoor.com/slink.htm?key=vMCfp
    #ARV7 #JCOCCI #genomichealth

    PROPHECY Validation Trial Publication :: Epic Sciences

    New data from the PROPHECY trial, published in the Journal of Clinical Oncology, demonstrate that detection of AR-V7 in circulating tumor cells (CTCs) in blood is predictive of whether men with mCRPC have become resistant to androgen-receptor signaling (ARS) inhibitors and have a low chance of benefit from further ARS therapy.

  • http://glassdoor.com/slink.htm?key=vQ3y3

    Genomic Health Marks More than 1 Million Patients Worldwide Who Have Benefited from Oncotype DX Testing in Personalizing Cancer Treatment Decisions to Improve Outcomes | Genomic Health, Inc.

    Back Pioneering Precision Medicine While Saving Healthcare Costs REDWOOD CITY, Calif., Jan. 7, 2019 /PRNewswire/ -- Genomic Health, Inc. (NASDAQ: GHDX) today announced that, in collaboration with physicians around the world, it has delivered more than 1 million Oncotype DX ® tests to cancer patients worldwide since it made its first test available to patients in 2004.

  • Listen to Bret Miller discuss his experience with hashtag#Oncotype DX and how the test played an instrumental role in his hashtag#breastcancer treatment decision.

    Male Breast Cancer Survivor | Health Professional Radio

    Bret Miller, breast cancer survivor and co-founder of the Male Breast Cancer Coalition , discusses his unique story and how genomic testing helped him determine the best course of treatment for his disease. He also talks about his nonprofit organization and its mission to help spread the word that breast cancer does not discriminate.

  • Intern Poster Fair 2018

  • "Genomic Health Employees Doing Life, Changing Work"

    http://glassdoor.com/slink.htm?key=vQQR5

Work at Genomic Health? Share Your Experiences

Genomic Health
  • Star
  • Star
  • Star
  • Star
  • Star
 
Click to Rate
or